查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599726

血糖值測量市場：按產品、年齡層、應用、最終用戶、分銷管道 - 全球預測 2025-2030

Blood Glucose Testing Market by Product (Glucose Meter, Insulin Pens, Insulin Pumps & Reservoirs), Age Group (Adults, Geriatrics, Pediatrics), Application, End-User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血糖值測量市場規模為193.7億美元，預計2024年將達212.1億美元，複合年成長率為9.76%，預計2030年將達372億美元。

血糖值測量市場範圍包括測量血糖水平的設備和技術，這對於糖尿病管理至關重要。監測血糖值對於有效管理糖尿病是必要的，因為維持適當的血糖值可以預防併發症。該應用擴展到慢性病管理、家庭保健和醫院。最終用途範圍包括診斷中心、醫療機構和在家自我測量的個別患者等多種領域。主要影響成長要素是糖尿病盛行率增加、健康意識提高、技術進步以及向微創或非侵入性產品的轉變。與連續血糖監測儀 (CGM) 和雲端基礎的平台整合的智慧醫療設備的激增正在創造新的商機。這些可以實現即時資料分析，改善患者治療結果，並提供遠端醫療解決方案等新穎的業務提案。電子醫療的擴展和量身定做的患者照護策略為尋求競爭優勢的市場領導帶來了希望。然而，市場面臨限制和挑戰，例如先進設備的高成本、嚴格的監管環境以及與資料監控相關的隱私問題。此外，技術依賴性可能會導致採用方面的差異，特別是在資源匱乏的環境中。創新和研究的機會包括開發具有成本效益的模型，提高準確性和易用性，特別是針對微創解決方案。將血糖監測與其他健康指標結合的綜合健康平台的進一步研究是一個富有成效的創新領域。全球研究合作可以產生研究工作的協同效應，增強產品功能並擴大市場範圍。市場動態是充滿活力和競爭的，其特點是快速的技術創新和高消費者期望。企業應專注於加強資料安全和監管合規性，同時投資消費者教育和可負擔性策略，以加強其市場佔有率和成長。

主要市場統計
基準年[2023] 193.7億美元
預測年份 [2024] 212.1億美元
預測年份 [2030] 372億美元
複合年成長率（%） 9.76%

市場動態：快速發展的血糖值測量市場的關鍵市場洞察

供需的動態交互作用正在改變血糖值測量市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球糖尿病發生率上升以及對有效血糖監測解決方案的需求
    • 在家庭醫療保健中擴大採用非侵入性血糖值測量設備
  • 市場限制因素
    • 血糖值測量設備高成本且精度有限
  • 市場機會
    • 政府對血糖值監測的優惠措施與報銷政策
    • 血糖監測設備的不斷進步與改進
  • 市場挑戰
    • 嚴格的監管要求和產品召回案例

波特五力：駕馭血糖值測量市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對血糖值測量市場的影響

外部宏觀環境因素在塑造血糖值測量市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解血糖值測量市場的競爭狀況

對血糖值監測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣血糖值測量市場廠商績效評估

FPNV定位矩陣是評估血糖值測量市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃血糖值測試市場的成功之路

血糖值測量市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球糖尿病發生率上升，需要有效的血糖監測解決方案
      • 在家庭醫療保健環境中擴大採用非侵入性血糖值測量設備
    • 抑制因素
      • 血糖值測量設備高成本且精度有限
    • 機會
      • 政府對血糖值測量的有利措施和報銷政策
      • 血糖值監測設備的不斷進步與改進
    • 任務
      • 嚴格的監管要求和產品召回案例
  • 市場區隔分析
    • 產品：採用CGM系統進行血糖值測量，避免嚴重的短期及長期糖尿病併發症
    • 應用：增加妊娠糖尿病中血糖值監測的使用，降低與多種慢性疾病相關的風險
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章血糖值測量市場：依產品

  • 血糖儀
    • 連續血糖監測
    • 快速血糖監測
  • 胰島素筆
  • 胰島素幫浦和儲液器
  • 採血針
  • 試紙條

第7章血糖值測量市場：依年齡層

  • 成人
  • 老年醫學
  • 小兒科

第8章血糖值測量市場：依應用分類

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

第9章血糖值測量市場：依最終用戶分類

  • 居家護理
  • 醫院/診所

第10章血糖值測量市場：按分銷管道

  • 離線
  • 線上

第11章北美和南美血糖值測量市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太血糖值測量市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的血糖值測量市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Focus與GlucoTrack合作開發植入式連續血糖監測儀
    • Beurer India 在印度市場推出血糖值監測設備
    • MTD 收購 Ipsomed 的筆針和背景音樂業務，鞏固在糖尿病護理領域的地位
  • 戰略分析和建議

公司名單

  • 77 Elektronika Kft.
  • Abbott Laboratories
  • ACON Laboratories, Inc
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Medical Ltd.
  • Becton Dickinson and Company
  • Beurer Belgium
  • Dexcom, Inc.
  • ForaCare Suisse AG
  • i-SENS, Inc.
  • Johnson & Johnson
  • LifeScan IP Holdings, LLC
  • Medisana AG
  • Medtronic PLC
  • Merck KGaA
  • Microlife AG
  • Neogen Corporation
  • Nipro Corporation
  • Nova Biomedical
  • Omron Healthcare, Inc.
  • Roche Diagnostics Nederland BV
  • Rossmax International Ltd.
  • Sanofi SA
  • Sinocare Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • VivaChek Laboratories Inc.
Product Code: MRR-030666397D38

The Blood Glucose Testing Market was valued at USD 19.37 billion in 2023, expected to reach USD 21.21 billion in 2024, and is projected to grow at a CAGR of 9.76%, to USD 37.20 billion by 2030.

The scope of the blood glucose testing market involves devices and technologies that measure glucose levels in the blood, crucial for diabetes management. Blood glucose monitoring is necessary to manage diabetes effectively, as maintaining the appropriate blood glucose levels prevents complications. This application extends to chronic disease management, home healthcare, and hospitals. The end-use scope includes diverse sectors such as diagnostic centers, healthcare institutions, and individual patients self-monitoring at home. Key influencing growth factors are the increasing prevalence of diabetes, rising health awareness, advancements in technology, and the shift towards minimally invasive or non-invasive products. The widespread adoption of continuous glucose monitors (CGMs) and smart medical devices integrated with cloud-based platforms offers fresh opportunities. These allow real-time data analytics, improving patient outcomes and offering novel business proposals, such as telehealth solutions. The expansion of e-health and tailored patient-care strategies is promising for market leaders aiming to gain a competitive edge. However, the market faces limitations and challenges, such as the high costs of advanced devices, stringent regulatory landscapes, and privacy concerns associated with data monitoring. Moreover, technological dependency may result in disparities in adoption, particularly in low-resource settings. Opportunities for innovation and research include developing cost-effective models with enhanced accuracy and ease of use, especially targeting minimally invasive solutions. Further research into integrated wellness platforms that combine glucose monitoring with other health metrics is a lucrative innovation area. Global collaborations can lead to synergized research efforts, enriching product features and expanding market reach. The nature of the blood glucose testing market is dynamic and competitive, characterized by rapid technological changes and high consumer expectations. Firms should focus on enhancing data security and regulatory compliance, alongside investing in consumer education and affordable pricing strategies, to bolster market presence and growth.

KEY MARKET STATISTICS
Base Year [2023] USD 19.37 billion
Estimated Year [2024] USD 21.21 billion
Forecast Year [2030] USD 37.20 billion
CAGR (%) 9.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Glucose Testing Market

The Blood Glucose Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Global rise in diabetes incidence and the need for effective glucose monitoring solutions
    • Rising adoption of non-invasive blood glucose testing devices in home healthcare settings
  • Market Restraints
    • High costs and limited accuracy of blood glucose testing devices
  • Market Opportunities
    • Favorable government initiatives and reimbursement policies for blood glucose testing
    • Ongoing advancements and improvements in blood glucose monitoring devices
  • Market Challenges
    • Strict regulatory requirements and cases of product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Blood Glucose Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Glucose Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Glucose Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Glucose Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Glucose Testing Market

A detailed market share analysis in the Blood Glucose Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Glucose Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Glucose Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Glucose Testing Market

A strategic analysis of the Blood Glucose Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Testing Market, highlighting leading vendors and their innovative profiles. These include 77 Elektronika Kft., Abbott Laboratories, ACON Laboratories, Inc, AgaMatrix, Inc., ARKRAY, Inc., Ascensia Diabetes Care Holdings AG, B. Braun Medical Ltd., Becton Dickinson and Company, Beurer Belgium, Dexcom, Inc., ForaCare Suisse AG, i-SENS, Inc., Johnson & Johnson, LifeScan IP Holdings, LLC, Medisana AG, Medtronic PLC, Merck KGaA, Microlife AG, Neogen Corporation, Nipro Corporation, Nova Biomedical, Omron Healthcare, Inc., Roche Diagnostics Nederland BV, Rossmax International Ltd., Sanofi S.A., Sinocare Inc., Terumo Corporation, Trividia Health, Inc., and VivaChek Laboratories Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Glucose Meter, Insulin Pens, Insulin Pumps & Reservoirs, Lancets, and Test Strips. The Glucose Meter is further studied across Continuous Glucose Monitoring and Flash Glucose Monitoring.
  • Based on Age Group, market is studied across Adults, Geriatrics, and Pediatrics.
  • Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
  • Based on End-User, market is studied across Home Care and Hospital & Clinics.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Global rise in diabetes incidence and the need for effective glucose monitoring solutions
      • 5.1.1.2. Rising adoption of non-invasive blood glucose testing devices in home healthcare settings
    • 5.1.2. Restraints
      • 5.1.2.1. High costs and limited accuracy of blood glucose testing devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable government initiatives and reimbursement policies for blood glucose testing
      • 5.1.3.2. Ongoing advancements and improvements in blood glucose monitoring devices
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory requirements and cases of product recalls
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Adoption of CGM systems in blood glucose to avoid serious, short- and long-term diabetes complications
    • 5.2.2. Application: Increasing uses of blood glucose testing in gestational diabetes to mitigate risks associated with several chronic diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Glucose Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Glucose Meter
    • 6.2.1. Continuous Glucose Monitoring
    • 6.2.2. Flash Glucose Monitoring
  • 6.3. Insulin Pens
  • 6.4. Insulin Pumps & Reservoirs
  • 6.5. Lancets
  • 6.6. Test Strips

7. Blood Glucose Testing Market, by Age Group

  • 7.1. Introduction
  • 7.2. Adults
  • 7.3. Geriatrics
  • 7.4. Pediatrics

8. Blood Glucose Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Gestational Diabetes
  • 8.3. Type 1 Diabetes
  • 8.4. Type 2 Diabetes

9. Blood Glucose Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Home Care
  • 9.3. Hospital & Clinics

10. Blood Glucose Testing Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Americas Blood Glucose Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Blood Glucose Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Blood Glucose Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Focus collaborates with GlucoTrack on implantable continuous blood glucose monitor
    • 14.3.2. Beurer India launches blood glucose monitor device in the Indian market
    • 14.3.3. MTD acquires Ypsomed's Pen Needle and BGM Businesses, strengthening Its position in diabetes care
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 77 Elektronika Kft.
  • 2. Abbott Laboratories
  • 3. ACON Laboratories, Inc
  • 4. AgaMatrix, Inc.
  • 5. ARKRAY, Inc.
  • 6. Ascensia Diabetes Care Holdings AG
  • 7. B. Braun Medical Ltd.
  • 8. Becton Dickinson and Company
  • 9. Beurer Belgium
  • 10. Dexcom, Inc.
  • 11. ForaCare Suisse AG
  • 12. i-SENS, Inc.
  • 13. Johnson & Johnson
  • 14. LifeScan IP Holdings, LLC
  • 15. Medisana AG
  • 16. Medtronic PLC
  • 17. Merck KGaA
  • 18. Microlife AG
  • 19. Neogen Corporation
  • 20. Nipro Corporation
  • 21. Nova Biomedical
  • 22. Omron Healthcare, Inc.
  • 23. Roche Diagnostics Nederland BV
  • 24. Rossmax International Ltd.
  • 25. Sanofi S.A.
  • 26. Sinocare Inc.
  • 27. Terumo Corporation
  • 28. Trividia Health, Inc.
  • 29. VivaChek Laboratories Inc.

LIST OF FIGURES

  • FIGURE 1. BLOOD GLUCOSE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD GLUCOSE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BLOOD GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BLOOD GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD GLUCOSE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY INSULIN PUMPS & RESERVOIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. BLOOD GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. BLOOD GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023